Facebook
Instagram
Linkedin
RSS
Telegram
Tumblr
Twitter
Website
Youtube
Sign in
Join
Home
Submit a press release
Partner Events
Partner with us
About us
Terms of use
Privacy policy
Contact us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Home
Submit a press release
Partner Events
Partner with us
About us
Terms of use
Privacy policy
Contact us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Middle East Business News and Information – mid-east.info
Home
Submit a press release
Partner Events
Partner with us
About us
Terms of use
Privacy policy
Contact us
Home
Pharmaceuticals
Hikma Pharmaceuticals
Hikma Pharmaceuticals
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Hikma acquires the rights to a portfolio of Takeda brands for the MENA region
December 20, 2024
Hikma continues strong strategic execution and reiterates guidance
Hikma delivers strong H1 preformance and raises Generics guidance
Good momentum across all businesses and updated Generics guidance
Hikma and Celltrion Healthcare sign new exclusive licensing agreement for Vegzelma® for the Middle East and North Africa region
Hikma and Adalvo Sign Exclusive Licensing Agreement to Commercialise Allergic Rhinitis...
August 25, 2022
Hikma’s diversified business delivers resilient H1 performance
August 4, 2022
Hikma continued strategic progress and updated full-year guidance following Custopharm acquisition
April 30, 2022
Hikma Ventures leads seed financing round for Egypt based O7 Therapy;...
April 4, 2022
Hikma Ventures Participates in USD 44 Million Financing Round for Altibbi...
March 30, 2022
Hikma delivers another year of profitable growth in 2021 and announces...
February 27, 2022
Hikma expands licensing agreement with Celltrion for Remsima® subcutaneous formulation in...
February 9, 2022
Hikma and Winterlight Labs PoC Collaboration
November 23, 2021
Hikma continues strong 2021 performance and reiterates full year guidance
November 9, 2021
Hikma and Almirall enter an exclusive licensing agreement to market FinjuveTM...
November 2, 2021
1
2
Page 1 of 2
Connect with us
1,825
Fans
Like
210
Followers
Follow
1,929
Followers
Follow
30
Subscribers
Subscribe
